| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.092 | 0.07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.032 | 0.5 |